Pharmacological Intervention for Symptomatic Mild Sleep Disordered Breathing
Sponsor: Apnimed
This PHASE2 trial investigates Sleep Disordered Breathing and is currently completed. Apnimed leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Apr 2022 — Jul 2024 [monthly]
Completed PHASE2
Status: Recruiting → Completed
-
Sep 2021 — Apr 2022 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Not Yet Recruiting PHASE2
▶ Show 1 earlier version
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Apnimed
- Brigham and Women's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .